
Cell Therapy, Devices, and Diabetes: Richard Youngblood
Richard is studying the feasibility of using stem cells and a microporous device as an approach for treating type 1 diabetes.

Cancer Whack-A-Mole: Melanie Krook, PhD
Profile of a grad school friend who is currently a post-doc studying tumor heterogeneity and drug resistance.

Helping Patients See the Future: ONL Therapeutics, Inc.
Highlighting a company that’s working to protect the vision of patients with retinal disease.

Fas and Cell Death: The Basic Story
Brief introduction into the science of Fas and its traditional role in cell death.

